Clearside Biomedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.About CLSD
Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases.
CEOGeorge M. Lasezkay
CEOGeorge M. Lasezkay
Employees32
Employees32
HeadquartersAlpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded2011
Founded2011
Employees32
Employees32
CLSD Key Statistics
Market cap20.41M
Market cap20.41M
Price-Earnings ratio-0.66
Price-Earnings ratio-0.66
Dividend yield—
Dividend yield—
Average volume89.88K
Average volume89.88K
High today$3.95
High today$3.95
Low today$3.61
Low today$3.61
Open price$3.64
Open price$3.64
Volume38.69K
Volume38.69K
52 Week high$24.75
52 Week high$24.75
52 Week low$3.32
52 Week low$3.32
Analyst ratings
86%
of 7 ratingsBuy
14.3%
Hold
85.7%
Sell
0%
People also own
Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.